NeoPharm CO., LTD. (KOSDAQ:092730)

South Korea flag South Korea · Delayed Price · Currency is KRW
21,200
+1,100 (5.47%)
Apr 28, 2026, 3:30 PM KST
60.24%
Market Cap 331.59B
Revenue (ttm) 132.18B
Net Income (ttm) 27.82B
Shares Out 15.64M
EPS (ttm) 1,778.81
PE Ratio 11.92
Forward PE 10.36
Dividend 750.00 (3.73%)
Ex-Dividend Date Dec 29, 2025
Volume 243,836
Average Volume 68,876
Open 20,200
Previous Close 20,100
Day's Range 20,200 - 21,300
52-Week Range 13,010 - 22,650
Beta 0.57
RSI 76.83
Earnings Date May 8, 2026

About NeoPharm CO., LTD.

NeoPharm CO., LTD. engages in the manufacturing and sale of skin care products in South Korea. The company provides Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand name; sensitive, dry, oily, or trouble-prone skin care products under the ZEROID brand; body moisturizers under the Derma-B brand name; sport care products under the MISSION ATHELETCARE brand; and dermArtlogy, a 1:1 consulting cosmetic brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, So... [Read more]

Founded 2000
Employees 178
Stock Exchange KOSDAQ
Ticker Symbol 092730
Full Company Profile

Financial Performance

In 2025, NeoPharm CO., LTD.'s revenue was 132.18 billion, an increase of 11.07% compared to the previous year's 119.01 billion. Earnings were 27.82 billion, an increase of 20.63%.

Financial Statements

News

There is no news available yet.